FrancophonIA/ELRC3.0 huggingface dataset:
English: In patients with chronic renal impairment whose creatinine clearance is < 30 ml/min and who are not receiving regularly scheduled haemodialysis, the recommended dose is reduced to either 1,000 mg administered as a single infusion or 750 mg followed one week later by 375 mg (see section 5.2).
Croatian: U bolesnika s kroničnim oštećenjem bubrega čiji je klirens kreatinina < 30 ml/min i koji se redovito ne podvrgavaju hemodijalizi, preporučena doza se smanjuje na 1000 mg dalbavancina u obliku jednokratne infuzije ili 750 mg nakon koje tjedan dana kasnije slijedi doza od 375 mg (vidjeti dio 5.2).
English: Skin and subcutaneous tissue disorders pruritus, urticaria, rash
Croatian: Poremećaji kože i potkožnog tkiva pruritus, urtikarija, osip
English: MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS Vial label
Croatian: PODACI KOJE MORA NAJMANJE SADRŽAVATI MALO UNUTARNJE PAKIRANJE
English: Dose-dependent toxicity included serum chemistry and histological evidence of renal and hepatic injury, reduced red blood cell parameters and injection site irritation.
Croatian: Toksičnost ovisna o dozi uključila je dokaze biokemijske pretrage seruma i histološke dokaze bubrežnog i jetrenog oštećenja, smanjene parametre eritrocita i nadražaj na mjestu primjene.
English: The experience with dalbavancin in elderly is limited: 276 patients ≥ 75 years of age were included in the Phase 2/3 clinical studies, of which 173 received dalbavancin.
Croatian: ≥ 75 godina bilo je uključeno u klinička ispitivanja faze 2/3, od kojih je 173 primilo dalbavancin.
English: Efficacy has been demonstrated in clinical studies against the pathogens listed for ABSSSI that were susceptible to dalbavancin in vitro:
Croatian: Djelotvornost je dokazana u kliničkim ispitivanjima protiv patogena navedenih za akutne bakterijske infekcije kože i kožnih struktura koji su bili osjetljivi na dalbavancin in vitro:
English: The vial contains white to off-white to pale yellow powder.
Croatian: Bočica sadrži prašak bijele ili gotovo bijele do blijedo žute boje.
English: In Phase 2 / 3 clinical studies, 2,473 patients received dalbavancin administered as either a single infusion of 1,500 mg or as 1,000 mg followed one week later by 500 mg.
Croatian: U kliničkim ispitivanjima faze 2/3, 2473 bolesnika su primila dalbavancin u obliku jednokratne infuzije od 1500 mg ili kao 1000 mg nakon čega je tjedan dana kasnije slijedila doza od 500 mg.
English: • Inflammation and swelling of surface veins, flushing
Croatian: • Upala i otjecanje površinskih vena, navale crvenila
English: After reconstitution each ml contains 20 mg dalbavancin.
Croatian: Nakon rekonstitucije jedan ml sadrži 20 mg dalbavancina.
English: Clinically significant gender-related differences in dalbavancin pharmacokinetics have not been observed in healthy subjects or in patients with infections.
Croatian: Spol Nisu uočene klinički značajne razlike povezane sa spolom u farmakokinetici dalbavancina u zdravih ispitanika ili bolesnika s infekcijom.
English: Sodium chloride containing solutions can cause precipitation and should NOT be used for reconstitution or dilution.
Croatian: Otopine koje sadrže natrijev klorid mogu uzrokovati taloženje i NE SMIJU se koristiti za rekonstituciju ili razrjeđivanje.
English: Mean plasma exposures for dalbavancin, based on AUCinf (17,495 µg•h/ml and 16,248 µg •h/ml) and Cmax (212 µg/ml and 191 µg/ml) were similar when administered as 1,000 mg to paediatric subjects (12-16 years) weighing > 60 kg (61.9 - 105.2 kg) or as 15 mg/kg to paediatric subjects weighing < 60 kg (47.9-58.9 kg).
Croatian: 248 µg •h/ml) i Cmax (212 µg/ml i 191 µg/ml) bile su slične kad je primijenjeno 1000 mg u pedijatrijskih ispitanika (12-16 godina) težine > 60 kg (61,9 - 105,2 kg) i kad je primijenjeno 15 mg/kg u pedijatrijskih ispitanika težine < 60 kg (47,9-58,9 kg).
English: Intravenous use after reconstitution and dilution.
Croatian: Za intravensku primjenu nakon rekonstitucije i razrjeđivanja.
English: Nervous system disorders headache dysgeusia, dizziness
Croatian: Poremećaji živčanog sustava glavobolja disgeuzija, omaglica
English: General disorders and administration site conditions infusion-related reactions
Croatian: Opći poremećaji i reakcije na mjestu primjene reakcije povezane s infuzijom
English: constipation, abdominal pain, dyspepsia, abdominal discomfort, vomiting
Croatian: konstipacija, bol u abdomenu, dispepsija, nelagoda u abdomenu, povraćanje
English: This has been reported as a side effect with a similar medicine.
Croatian: • Promjene sluha zabilježene su kao nuspojava sličnog lijeka.
English: Estimated pharmacokinetic parameters of dalbavancin following the two-dose regimen and the single-dose regimen, respectively, are shown in Table 2 below.
Croatian: Procijenjeni farmakokinetički parametri dalbavancina nakon dvokratne i jednokratne primjene doza prikazani su u Tablici 2. u nastavku.
English: The reconstituted concentrate in the vial contains 20 mg/ml dalbavancin.
Croatian: Rekonstituirani koncentrat u bočici sadrži 20 mg/ml dalbavancina.
English: It is unknown whether dalbavancin is excreted in human milk.
Croatian: Nije poznato izlučuje li se dalbavancin u majčino mlijeko u ljudi.
English: For dosing instructions in subjects with hepatic impairment refer to section 4.2.
Croatian: Za upute o doziranju u ispitanika s oštećenjem bubrega vidjeti dio 4.2.
English: Resistance to dalbavancin in Staphylococcus spp.
Croatian: Rezistencija na dalbavancin kod Staphylococcus spp. i Enterococcus spp. posredovana je s VanA,
English: Do not use this medicine after the expiry date which is stated on the vial after EXP.
Croatian: Ovaj lijek se ne smije upotrijebiti nakon isteka roka valjanosti navedenog na bočici iza oznake „Rok valjanosti“.
English: To dilute the reconstituted concentrate, the appropriate volume of the 20 mg / ml concentrate must be transferred from the vial to an intravenous bag or bottle containing 50 mg/ml (5 %) glucose solution for infusion.
Croatian: Za razrjedivanje rekonstituiranog koncentrata, odgovarajući volumen koncentrata od 20 mg/ml mora se iz bočice prebaciti u vrećicu ili bocu za intravensku infuziju koja sadrži 5%-tnu (50 mg/ml) otopinu glukoze za infuziju.
English: It is not known if dalbavancin is a substrate for hepatic uptake and efflux transporters.
Croatian: Nije poznato je li dalbavancin supstrat jetrenih transportera unosa i efluksa.
English: : Susceptible ≤ 0.125 mg/l; Resistant > 0.125 mg/l,
Croatian: • Staphylococcus spp.: Osjetljiv ≤ 0,125 mg/l; Rezistentan > 0,125 mg/l,
English: Ototoxicity has been associated with glycopeptide use (vancomycin and teicoplanin); patients who are receiving concomitant therapy with an ototoxic medicinal product, such as an aminoglycoside, may be at increased risk.
Croatian: Bolesnici koji primaju istodobnu terapiju ototoksičnim lijekom, kao što je aminoglikozid, mogu biti pod povećanim rizikom.
English: Aseptic technique must be used for reconstitution and dilution of Xydalba.
Croatian: Za rekonstituciju i razrjeđivanje Xydalbe mora se koristiti aseptička tehnika.
English: Dalbavancin toxicity has been evaluated after daily intravenous administration for durations of up to
Croatian: Toksičnost dalbavancina procijenjena je nakon svakodnevne intravenske primjene u trajanju do 3 mjeseca kod štakora i pasa.
English: Xydalba must be reconstituted with sterile water for injections and subsequently diluted with 50 mg/ml (5 %) glucose solution for infusion.
Croatian: Xydalba se mora rekonstituirati sterilnom vodom za injekcije i nakon toga razrijediti 5%-tnom (50 mg/ml) otopinom glukoze za infuziju.
English: The dalbavancin plasma concentration-time following the two-dose and the single-dose regimens, respectively, are shown in Figure 1.
Croatian: Vrijeme dostignute koncentracije dalbavancina u plazmi nakon dvokratne i jednokratne doze prikazano je na Slici 1.
English: Recommended dose and duration of treatment for adults The recommended dose of dalbavancin in adult patients with ABSSSI is 1,500 mg administered as either a single infusion of 1,500 mg or as 1,000 mg followed one week later by 500 mg (see sections 5.1 and 5.2).
Croatian: Preporučena doza dalbavancina u odraslih bolesnika s akutnom bakterijskom infekcijom kože i kožnih struktura je ili 1500 mg u obliku jednokratne infuzije ili 1000 mg u infuziji nakon koje tjedan dana kasnije slijedi druga infuzija u dozi od 500 mg (vidjeti dijelove 5.1 i 5.2).
English: • Peptostreptococcus spp.
Croatian: • Clostridium perfringens, • Peptostreptococcus spp.
English: Xydalba is not recommended during pregnancy unless clearly necessary.
Croatian: Xydalba se ne preporučuje u trudnoći osim ako to nije neophodno, zbog toga što nije poznat učinak lijeka na nerođeno dijete.
English: Respiratory, thoracic and mediastinal disorders cough bronchospasm
Croatian: Poremećaji dišnog sustava, prsišta i sredoprsja kašalj bronhospazam
English: Single-dose regimen3
Croatian: Jednokratna doza3
English: Package leaflet: Information for the patient Xydalba 500 mg powder for concentrate for solution for infusion dalbavancin
Croatian: Uputa o lijeku: Informacija za bolesnika Xydalba 500 mg prašak za koncentrat za otopinu za infuziju dalbavancin
English: RO-București 050451
Croatian: Dr. Carol Davila, Nr. 9, Sector 5 RO-București 050451
English: The compatibility of reconstituted Xydalba concentrate has only been established with 50 mg/ml (5 %) glucose solution for infusion.
Croatian: Kompatibilnost rekonstituiranog koncentrata lijeka Xydalba ustanovljena je samo s 5%-tnom (50 mg/ml) otopinom glukoze za infuziju.
English: White to off-white to pale yellow powder.
Croatian: Prašak bijele ili gotovo bijele do blijedo žute boje.
English: Xydalba vials are for single-use only.
Croatian: Bočice s Xydalbom namijenjene su samo za jednokratnu uporabu.
English: A decision must be made whether to continue/discontinue breast-feeding or to continue/discontinue therapy with Xydalba taking into account the benefit of breast-feeding for the child and the benefit of therapy for the woman.
Croatian: Potrebno je odlučiti da li nastaviti/prekinuti dojenje ili nastaviti/prekinuti liječenje lijekom
English: The mean AUC was unchanged in subjects with mild hepatic impairment compared to subjects with normal hepatic function; however, the mean AUC decreased by 28 % and 31 %, respectively, in subjects with moderate and severe hepatic impairment.
Croatian: Međutim, srednja vrijednost AUC smanjena je za 28 % kod ispitanika s umjerenim, odnosno 31 % kod ispitanika s teškim oštećenjem jetre.
English: Cross-resistance between dalbavancin and other classes of antibiotics was not seen in in vitro studies.
Croatian: Križna rezistencija između dalbavancina i drugih skupina antibiotika nije primijećena u in vitro ispitivanjima.Rezistencija na meticilin ne utječe na aktivnost dalbavancina.
English: Xydalba must be reconstituted and then further diluted prior to administration by intravenous infusion over a 30 - minute period.
Croatian: Intravenska primjena Xydalba se mora rekonstituirati i nakon toga razrijediti prije primjene intravenskom infuzijom tijekom
English: Koidu str. 20-19
Croatian: Lorenzo Pharma OÜ Koidu str. 20-19
English: Tell your doctor or nurse immediately if you are concerned that you may have been given too much Xydalba.
Croatian: Odmah obavijestite svog liječnika ili medicinsku sestru ako ste zabrinuti da ste primili previše lijeka
English: In Phase 1 studies, healthy volunteers have been administered single doses of up to 1,500 mg, and cumulative doses up to 4,500 mg over a period of up to 8 weeks, with no signs of toxicity or laboratory results of clinical concern.
Croatian: U ispitivanjima faze 1, zdravi dobrovoljci primili su jednokratne doze do 1500 mg i kumulativne doze do 4500 mg tijekom razdoblja do
English: If particulate matter or discoloration is identified, the solution must be discarded.
Croatian: Ako otopina sadrži čestice ili promijeni boju, mora se baciti.
English: The reconstituted concentrate must be further diluted with 50 mg/ml (5 %) glucose solution for infusion.
Croatian: Rekonstituirani koncentrat mora se dodatno razrijediti 5 %-tnom (50 mg/ml) otopinom glukoze za infuziju.
English: For dosing instructions in subjects with renal impairment refer to section 4.2.
Croatian: Za upute o doziranju u ispitanika s oštećenjem jetre vidjeti dio 4.2.
English: Infections and infestations vulvovaginal mycotic infection, urinary tract infection, fungal infection, Clostridioides (formerly Clostridium) difficile colitis, oral candidiasis
Croatian: Infekcije i infestacije vulvovaginalna gljivična infekcija, infekcija mokraćnog trakta, gljivična infekcija, kolitis uzrokovan bakterijom
English: • Abdominal pain (stomach ache) and/or watery diarrhoea.
Croatian: • Bol u trbuhu i/ili vodenasti proljev.
English: Lactose monohydrate Hydrochloric acid (for pH-adjustment) Sodium hydroxide (for pH-adjustment)
Croatian: 6.1 Popis pomoćnih tvari manitol (E421) laktoza hidrat kloridna kiselina (za podešavanje pH ) natrijev hidroksid (za podešavanje pH )
English: Xydalba 500 mg powder for concentrate for solution for infusion
Croatian: Xydalba 500 mg prašak za koncentrat za otopinu za infuziju
English: Vascular disorders flushing, phlebitis
Croatian: Krvožilni poremećaji navale crvenila, flebitis
English: Tel: + 421 2 59 207 320 office@angelini.sk
Croatian: SK-831 01 Bratislava Tel: + 421 2 59 207 320 office@angelini.sk
English: Intravenous infusions with these types of antibiotics can cause flushing of the upper body, hives, itching and/or rashes.
Croatian: Reakcije povezane s infuzijom Intravenske infuzije s ovim vrstama antibiotika mogu uzrokovati navale crvenila gornjeg dijela tijela,
English: Xydalba 500 mg powder for concentrate for solution for infusion dalbavancin
Croatian: Xydalba 500 mg prašak za koncentrat za otopinu za infuziju dalbavancin
English: Angelini Pharma Slovenská republika s.r.o.
Croatian: Angelini Pharma Slovenská republika s.r.o. Júnová 33
English: Uncommon - may affect up to 1 in 100 people: Vaginal infections, fungal infections, oral thrush Urinary tract infections Anaemia (low levels of red blood cells), high blood platelet counts (thrombocytosis), increased blood counts of a type of white blood cell called eosinophils (eosinophilia), low levels of other types of white blood cell (leucopenia, neutropenia) Changes in other blood tests Decreased appetite
Croatian: povećani broj bijelih krvnih stanica zvanih eozinofili (eozinofilija), niska razina drugih vrsta bijelih krvnih stanica (leukopenija, neutropenija)
English: Each vial contains dalbavancin hydrochloride equivalent to 500 mg of dalbavancin.
Croatian: Jedna bočica sadrži dalbavancinklorid što odgovara 500 mg dalbavancina.
English: EXP
Croatian: • Osip
English: Angelini Pharmaceuticals România SRL Str. Dr. Carol Davila, Nr. 9, Sector 5
Croatian: Angelini Pharmaceuticals România SRL Str.
English: Sodium hydroxide and/or hydrochloric acid (for pH adjustment)
Croatian: manitol (E421), laktoza hidrat, natrijev hidroksid i/ili kloridna kiselina (za podešavanje pH)
English: Each vial of powder contains dalbavancin hydrochloride equivalent to 500 mg of dalbavancin.
Croatian: NAVOĐENJE DJELATNE(IH) TVARI Jedna bočica sadrži dalbavancinklorid što odgovara 500 mg dalbavancina.
English: Lactose monohydrate,
Croatian: Nakon jednokratne intravenske doze od
English: Teл.
Croatian: Xydalbe.
English: Powder for concentrate for solution for infusion 1 vial
Croatian: Prašak za koncentrat za otopinu za infuziju.
English: • Abdominal pain and discomfort, indigestion, constipation
Croatian: • Bol i nelagoda u trbuhu, probavne tegobe, zatvor
English: Two-dose regimen2
Croatian: Dvokratna doza2
English: Mannitol (E421)
Croatian: office@angelini.bg
English: A distance of at least 1 cm is to be maintained.
Croatian: Mora se održati udaljenost od najmanje 1 cm (centimetar).
English: Patients with more than 1 BCC
Croatian: Bolesnici s više od 1 BCC
English: No experience exists with these situations.
Croatian: Nema iskustava s tim situacijama.
English: Subgroups:
Croatian: Ukupno Podskupine:
English: However, in some cases they may persist for 1 to 2 weeks or even longer.
Croatian: Međutim, u nekim slučajevima se mogu zadržati 1 do 2 tjedna ili čak duže.
English: Allemagne / Deutschland / Duitsland / Германия / Německo / Saksamaa / Γερμανία / Njemačka / Germany / Þýskaland / Germania / Vācija / Vokietija / Németország / Il-Ġermanja / Niemcy /
Croatian: Allemagne / Deutschland / Duitsland / Германия / Německo / Saksamaa / Γερμανία / Njemačka / Germany / Þýskaland / Germania / Vācija / Vokietija / Németország / Il-Ġermanja / Niemcy / Alemanha / Nemčija / Nemecko,
English: It is used to treat:
Croatian: Upotrebljava se za liječenje:
English: In conclusion, even though subgroup sizes are too small to draw significant conclusions on individual groups, the distribution of the two products to the relevant subgroups is very similar.
Croatian: U zaključku, iako su veličine podskupina premale da bi se mogli izvući značajni zaključci za pojedinačne skupine, raspodjela ova dva lijeka u relevantnim podskupinama vrlo je slična.
English: - allergic reaction1
Croatian: − alergijska reakcija1
English: Date of latest renewal: 21 November 2016
Croatian: Datum posljednje obnove odobrenja: 21. studenog 2016.
English: • if you have impaired formation of red blood pigment called porphyria
Croatian: • ako imate oštećeno stvaranje crvenog krvnog pigmenta zvano porfirija
English: Thus, it seems not plausible that this could negatively impact the non-inferiority claim of the primary study endpoint or the general trends observed across all subgroups.
Croatian: Stoga se ne čini vjerojatnim da bi to moglo negativno utjecati na tvrdnju o neinferiornosti primarne mjere ishoda ispitivanja ili općih trendova opaženih u svim podskupinama.
English: All these adverse reactions were non serious.
Croatian: Nijedna od tih nuspojava nije bila ozbiljna.
English: Lower 97.5% Confidence Limit
Croatian: Donja granica 97,5% raspona pouzdanosti
English: See also section 6.6.
Croatian: Vidjeti također dio 6.6.
English: Risk of allergic reaction
Croatian: Rizik od alergijske reakcije
English: UNIQUE IDENTIFIER - 2D BARCODE 2D barcode carrying the unique identifier.
Croatian: 17. JEDINSTVENI IDENTIFIKATOR - 2D BARKOD Sadrži 2D barkod s jedinstvenim identifikatorom.
English: Each lamp should be used according to the user manual.
Croatian: Svaka se lampa mora koristiti u skladu s korisničkim priručnikom.
English: Adverse events and tolerability were comparable for both treatments.
Croatian: Štetni događaji i podnošljivost bili su usporedivi u oba liječenja.
English: The dressing is removed after 3 hours.
Croatian: Zavoj se uklanja nakon 3 sata.
English: - change of colour
Croatian: − promjena boje
English: Your doctor will decide how well each skin lesion has responded, and treatment may have to be repeated at this time.
Croatian: Liječnik će odlučiti koliko je dobro svaka lezija odgovorila na liječenje, koje se tada možda mora ponoviti.
English: The light dose delivered should be monitored if a suitable detector is available.
Croatian: Primijenjena doza svjetlosti mora se pratiti ako je dostupan odgovarajući detektor.
English: Ameluz transiently increases phototoxicity
Croatian: Ameluz prolazno pojačava fototoksičnost
English: Talk to your doctor before using Ameluz.
Croatian: Obratite se svom liječniku prije nego primijenite Ameluz.
English: Keep the tube tightly closed after first opening.
Croatian: Tubu čuvati čvrsto zatvorenu nakon prvog otvaranja.
English: Table 3a: Skin quality parameters in the treated area during 12- month follow-up
Croatian: Tablica 3a: Parametri kvalitete kože na liječenom području tijekom 12-mjesečnog praćenja
English: Positive allergy tests were reported in the study.
Croatian: U tom ispitivanju prijavljeni su pozitivni alergijski testovi.
English: Ameluz daylight photodynamic therapy is feasible all year long in southern Europe, from February to October in middle Europe, and from March to October in northern Europe.
Croatian: Fotodinamska terapija pod danjim svjetlom uz Ameluz moguća je tijekom cijele godine u južnoj Europi, od veljače do listopada u srednjoj Europi te od ožujka do listopada u sjevernoj Europi.
English: If Ameluz is accidentally ingested, systemic toxicity is unlikely.
Croatian: Ako se Ameluz nehotično proguta, sistemska toksičnost je malo vjerojatna.
English: Protoporphyrin IX is activated by illumination with red light of a suitable wavelength and energy.
Croatian: Protoporfirin IX se aktivira osvjetljavanjem crvenim svjetlom odgovarajuće valne duljine i energije.
English: After 24 hours, the mean cumulative absorption (including accumulation in the dermis) through human skin was 0.2% of the administered dose.
Croatian: Nakon 24 sata prosječna kumulativna apsorpcija (uključujući akumulaciju u dermisu) kroz ljudsku kožu bila je 0,2% primijenjene doze.
English: • rash, red or purple spots on the body
Croatian: • osip, crvene ili ljubičaste točkice po tijelu
English: BCC on the head (only)
Croatian: BCC (samo) na glavi
English: Posology in adults
Croatian: Doziranje u odraslih
English: Actinic keratoses are certain changes in the outer layer of the skin that can lead to skin cancer.
Croatian: Aktiničke keratoze su određene promjene u vanjskom sloju kože koje mogu dovesti do raka kože.
English: Non-clinical data reveal no special hazard for humans based on dermal toxicity studies or studies reported in the literature of repeated dose toxicity, genotoxicity and reproductive toxicity.
Croatian: Neklinički podaci ne ukazuju na poseban rizik za ljude na temelju ispitivanja dermalne toksičnosti ili ispitivanja iz literature toksičnosti ponovljenih doza, genotoksičnosti i reproduktivne toksičnosti.
English: Only CE marked lamps should be used, equipped with the necessary filters and/or reflecting mirrors to minimize exposure to heat, blue light and ultra violet (UV) radiation.
Croatian: Smiju se upotrijebiti samo lampe s CE oznakom, opremljene potrebnim filtrima i/ili reflektirajućim zrcalima za smanjenje izloženosti vrućini, plavoj svjetlosti i ultraljubičastom (UV) zračenju.
English: Do not use Ameluz:
Croatian: Nemojte primjenjivati Ameluz:
English: Special care should be taken to avoid bleeding during lesion preparation in such patients (see section 4.2).
Croatian: Potreban je poseban oprez kako bi se izbjeglo krvarenje tijekom pripreme lezije u takvih bolesnika (vidjeti dio 4.2).
English: In 12 cases the reactions started before illumination.
Croatian: Reakcije su u 12 slučajeva započele prije osvjetljavanja.
English: to <1/1,000), very rare (<1/10,000), and not known (cannot be estimated from the available data).
Croatian: <1/100), rijetko (≥1/10 000 do <1/1000), vrlo rijetko (<1/10 000) i nepoznato (ne može se procijeniti iz dostupnih podataka).
English: Actinic keratosis lesion severity was graded according to the scale described by Olsen et al., 1991 (J Am Acad Dermatol 1991; 24: 738-743):
Croatian: Težina lezija aktiničke keratoze ocjenjivana je u skladu s ljestvicom po Olsenu et al., 1991 (J Am Acad Dermatol 1991; 24: 738-743):
English: • In very rare cases photodynamic therapy may increase the risk of developing temporary memory loss.
Croatian: • U vrlo rijetkim slučajevima, fotodinamska terapija može povećati rizik od razvoja privremenog gubitka pamćenja.
English: The latter causes damage of cellular components and eventually destroys the target cells.
Croatian: To uzrokuje oštećenje staničnih komponenti i u konačnici razara ciljane stanice.
English: Protection from sun light exposure for 48 hours and observation are nevertheless recommended.
Croatian: Ipak, preporučuje se zaštita od izlaganja sunčevom svjetlu tijekom 48 sati i promatranje.
English: During illumination, patient and medical personnel should wear suitable protective goggles.
Croatian: Tijekom osvjetljavanja bolesnik i zdravstveno osoblje trebaju nositi odgovarajuće zaštitne naočale.
English: In the presence of oxygen, reactive oxygen species are formed.
Croatian: U prisutnosti kisika, nastaju reaktivni kisikovi spojevi.
English: These factors vary with lamp type.
Croatian: Ti se čimbenici razlikuju ovisno o tipu lampe.